Pharmacokinetic Comparison Of FK-506 Formulations
Steady-state Pharmacokinetic Comparison Of FK-506 Formulations
1. Renal transplant recipients, males or females, of 18 years of age or above.
2. Able to participate and willing to give written informed consent and to comply with
study visits and restrictions.
3. Able to understand English.
4. Patients having received a primary or secondary renal transplant
1. Evidence of acute rejection episode within the past three months prior to screening.
2. Recipients of organ transplants other than kidney.
3. Patients who are known to be HIV positive.